MC2278A1 - NEW PURICAL DERIVATIVES - Google Patents

NEW PURICAL DERIVATIVES

Info

Publication number
MC2278A1
MC2278A1 MC912204A MC2204A MC2278A1 MC 2278 A1 MC2278 A1 MC 2278A1 MC 912204 A MC912204 A MC 912204A MC 2204 A MC2204 A MC 2204A MC 2278 A1 MC2278 A1 MC 2278A1
Authority
MC
Monaco
Prior art keywords
purical
derivatives
new
purical derivatives
new purical
Prior art date
Application number
MC912204A
Other languages
French (fr)
Inventor
Jaunin Roland
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2278A1 publication Critical patent/MC2278A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC912204A 1990-07-18 1991-07-11 NEW PURICAL DERIVATIVES MC2278A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH238790 1990-07-18

Publications (1)

Publication Number Publication Date
MC2278A1 true MC2278A1 (en) 1993-06-23

Family

ID=4232597

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912204A MC2278A1 (en) 1990-07-18 1991-07-11 NEW PURICAL DERIVATIVES

Country Status (13)

Country Link
EP (1) EP0467207A3 (en)
JP (1) JPH04234391A (en)
KR (1) KR920002600A (en)
AU (1) AU8038491A (en)
CA (1) CA2044806A1 (en)
FI (1) FI913407A7 (en)
HU (1) HU209591B (en)
IE (1) IE912500A1 (en)
IL (1) IL98812A0 (en)
MC (1) MC2278A1 (en)
NO (1) NO912804L (en)
PT (1) PT98348A (en)
ZA (1) ZA915418B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5202328A (en) * 1991-03-06 1993-04-13 Merck & Co., Inc. Substituted fused pyrimidinones
TW274551B (en) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
PE20030008A1 (en) 2001-06-19 2003-01-22 Bristol Myers Squibb Co DUAL INHIBITORS OF PDE 7 AND PDE 4
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use

Also Published As

Publication number Publication date
EP0467207A2 (en) 1992-01-22
HU209591B (en) 1994-08-29
NO912804L (en) 1992-01-20
NO912804D0 (en) 1991-07-17
KR920002600A (en) 1992-02-28
JPH04234391A (en) 1992-08-24
IE912500A1 (en) 1992-01-29
CA2044806A1 (en) 1992-01-19
PT98348A (en) 1992-05-29
HU912347D0 (en) 1991-12-30
HUT58736A (en) 1992-03-30
EP0467207A3 (en) 1992-08-12
ZA915418B (en) 1992-03-25
AU8038491A (en) 1992-01-23
FI913407A7 (en) 1992-01-19
FI913407A0 (en) 1991-07-15
IL98812A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
FI930262L (en) KINUCLIDEN DERIVATIVES
DE69119329D1 (en) Actinonine derivatives
FI925523A0 (en) HYDROXI-OCH ALCOXYPYRIDE DERIVATIVES
DE69125099D1 (en) INDOLDER DERIVATIVES
MA22729A1 (en) NEW PEPTIDE DERIVATIVES
FI913045A7 (en) Heterocyclen derivatives
MA22407A1 (en) NEW STEROIDS-ESTERS
FI915507A7 (en) Aryl derivatives
FI925069L (en) NERVSKYDDANDE INDOLON OCH NAERA ANSLUTANDE DERIVATIVES
FI932082L (en) Foerbaettringar i och angaoende fotrande av roerledningar
FI930878L (en) A-SUBSTITUERADE TRYPTOPHAN-DIPEPTOIDDER DERIVATIVES
FI922347A7 (en) Azoxindole derivatives
ATE144765T1 (en) HIV-INHIBITING BENZENACETAMIDE DERIVATIVES
FI913094A7 (en) Polysaccharide derivatives
DE69130255D1 (en) OXADOL DERIVATIVES
FI930109L (en) 4-ALKYL-IMIDAZOLE DERIVATIVES
DK0472733T3 (en) Phenanthrend derivatives
TR26336A (en) SUBSTITUTED PIRAZOLINE DERIVATIVES
FI912598A7 (en) Dioxo-tetrahydroquinoline derivatives
MC2278A1 (en) NEW PURICAL DERIVATIVES
FI912759A7 (en) Pyridinylpiperazine derivatives
FI941863A7 (en) Oxazolidone derivative
FR2727680B1 (en) NEW 5-PYRROLYL-6-HALOGENO-2- PYRIDYLMETHYLSUFINYLBENZIMIDAZOLE DERIVATIVES
FI932928A7 (en) New benzodiazepine derivatives
FI911925A7 (en) Amine derivatives